IMMU-17. REDUCING THE EX VIVO MANUFACTURING TIME OF EGFRVIII-SPECIFIC CHIMERIC ANTIGEN RECEPTOR (CAR) T CELLS IMPROVES PHENOTYPE AND DEMONSTRATES POTENT ANTI-GLIOMA FUNCTION IN VIV...

od Tanaka, Ryuma, Caruso, Hillary, Ling, Xiaoyang, Najjar, Amer, Heimberger, Amy
Izdano u Neuro Oncol (2017)

IMMU-36. IMMUNE RESPONSES IN CANINE GLIOMAS ARE ENRICHED AT THE INFILTRATING EDGE OF ASTROCYTOMAS

od Kassab, Cynthia, Levine, Jonathan, Boudreau, Beth, Ling, Xiaoyang, Burks, Jared K, Zhou, Shouhao, Verhaak, Roel, Heimberger, Amy
Izdano u Neuro Oncol (2018)

The CXCR4 Antagonist AMD3465 Regulates Oncogenic Signaling and Invasiveness In Vitro and Prevents Breast Cancer Growth and Metastasis In Vivo

od Ling, Xiaoyang, Spaeth, Erika, Chen, Ye, Shi, Yuexi, Zhang, Weiguo, Schober, Wendy, Hail, Numsen, Konopleva, Marina, Andreeff, Michael
Izdano 2013

MRx102, a triptolide derivative, has potent antileukemic activity in vitro and in a murine model of AML

od Carter, Bing Z., Mak, Duncan H., Shi, Yuxie, Fidler, John M., Chen, Rong, Ling, Xiaoyang, Plunkett, William, Andreeff, Michael
Izdano 2011

SCIDOT-23. LOW INTENSITY PULSED ULTRASOUND ENHANCES BLOOD-BRAIN BARRIER OPENING AND IMPROVES RESPONSE TO IMMUNOTHERAPY FOR GLIOBLASTOMA

od Sabbagh, Aria, Marisetty, Anantha, Ott, Martina, Ling, Xiaoyang, Barton, Emily, Caruso, Hillary, Kong, Ling-Yuan, Rao, Ganesh, Canney, Michael, Heimberger, Amy B
Izdano u Neuro Oncol (2019)

IMPS-34 INNATE IMMUNOLOGICAL COMPENSATORY CONTROL OF GLIOMAGENESIS AND MALIGNANT TRANSFORMATION IN MURINE CD8α KNOCKOUT MODELS

od Rao, Ganesh, Ling, Xiaoyang, Doucette, Tiffany, Yang, Yuhui, Kong, Ling-Yuan, Wei, Jun, Fuller, Gregory, Nwajei, Felix, Zhou, Shouhao, Caruso, Hillary, Vile, Richard, Heimberger, Amy
Izdano u Neuro Oncol (2015)

Mesenchymal Stem Cells Overexpressing IFN-β Inhibit Breast Cancer Growth and Metastases through Stat3 Signaling in a Syngeneic Tumor Model

od Ling, Xiaoyang, Marini, Frank, Konopleva, Marina, Schober, Wendy, Shi, Yuexi, Burks, Jared, Clise-Dwyer, Karen, Wang, Rui-Yu, Zhang, Weiguo, Yuan, Xiaoqing, Lu, Hongbo, Caldwell, Lisa, Andreeff, Michael
Izdano 2010

Targeting the leukemia microenvironment by CXCR4 inhibition overcomes resistance to kinase inhibitors and chemotherapy in AML

od Zeng, Zhihong, Xi Shi, Yue, Samudio, Ismael J., Wang, Rui-Yu, Ling, Xiaoyang, Frolova, Olga, Levis, Mark, Rubin, Joshua B., Negrin, Robert R., Estey, Elihu H., Konoplev, Sergej, Andreeff, Michael, Konopleva, Marina
Izdano 2009

Tumor Trp53 status and genotype affect the bone marrow microenvironment in acute myeloid leukemia

od Jacamo, Rodrigo, Davis, R. Eric, Ling, Xiaoyang, Sonnylal, Sonali, Wang, Zhiqiang, Ma, Wencai, Zhang, Min, Ruvolo, Peter, Ruvolo, Vivian, Wang, Rui-Yu, McQueen, Teresa, Lowe, Scott, Zuber, Johannes, Kornblau, Steven M., Konopleva, Marina, Andreeff, Michael
Izdano u Oncotarget (2017)

IMPS-41 IMMUNE MODULATORY NANOPARTICLE THERAPEUTICS

od Yaghi, Nasser, Wei, Jun, Hashimoto, Yuuri, Kong, Ling-Yuan, Gabrusiewicz, Konrad, Nduom, Edjah, Ling, Xiaoyang, Huang, Neal, Zhou, Shouhao, Levine, Jonathan, Fajt, Virginia, Levine, Gwendolyn, Porter, Brian, Tachikawa, Kiyoshi, Chivukula, Padmanabh, Webb, David, Payne, Joseph, Heimberger, Amy
Izdano u Neuro Oncol (2015)

Role of peroxisome proliferator-activated receptor-γ and its co-activator DRIP205 in cellular responses to CDDO (RTA-401) in AML

od Tsao, Twee, Kornblau, Steven, Safe, Stephen, Watt, Julie C., Ruvolo, Vivian, Chen, Wenjing, Qiu, Yihua, Coombes, Kevin R., Ju, Zhenlin, Abdelrahim, Maen, Schober, Wendy, Ling, Xiaoyang, Kardassis, Dimitris, Meyer, Colin, Schimmer, Aaron, Kantarjian, Hagop, Andreeff, Michael, Konopleva, Marina
Izdano 2010

MiR-138 exerts anti-glioma efficacy by targeting immune checkpoints

od Wei, Jun, Nduom, Edjah K., Kong, Ling-Yuan, Hashimoto, Yuuri, Xu, Shuo, Gabrusiewicz, Konrad, Ling, Xiaoyang, Huang, Neal, Qiao, Wei, Zhou, Shouhao, Ivan, Cristina, Fuller, Greg N., Gilbert, Mark R., Overwijk, Willem, Calin, George A., Heimberger, Amy B.
Izdano u Neuro Oncol (2016)

IMPS-28 PD-L1 EXPRESSION AND PROGNOSTIC IMPACT IN GLIOBLASTOMA

od Nduom, Edjah K., Wei, Jun, Yaghi, Nasser, Huang, Neal, Kong, Ling-Yuan, Gabrusiewicz, Konrad, Ling, Xiaoyang, Zhou, Shouhao, Ivan, Cristina, Chen, Jie Qing, Burks, Jared, Fuller, Greg, Calin, George, Conrad, Charles, Creasy, Caitlin, Ritthipichai, Krit, Radvanyi, Laszlo, Heimberger, Amy
Izdano u Neuro Oncol (2015)

Anti-PD-1 induces M1 polarization in the glioma microenvironment and exerts therapeutic efficacy in the absence of CD8 cytotoxic T cells

od Rao, Ganesh, Latha, Khatri, Ott, Martina, Sabbagh, Aria, Marisetty, Anantha, Ling, Xiaoyang, Zamler, Daniel, Doucette, Tiffany A., Yang, Yuhui, Kong, Ling-Yuan, Wei, Jun, Fuller, Gregory N., Benavides, Fernando, Sonabend, Adam M., Long, James, Li, Shulin, Curran, Michael, Heimberger, Amy B.
Izdano u Clin Cancer Res (2020)

GENE-57. COMPARATIVE MOLECULAR LIFE HISTORY OF SPONTANEOUS CANINE AND HUMAN GLIOMA

od Amin, Samirkumar, Anderson, Kevin, Bourdreau, Beth, Martínez, Emmanuel, Kocakavuk, Emre, Johnson, Kevin C, Barthel, Floris, Varn, Frederick, Kassab, Cynthia, Ling, Xiaoyang, Kim, Hoon, Barther, Mary, Yee Ngan, Chew, Dickinson, Peter, Packer, Rebecca, Taylor, Amanda, Rossmeisl, John, Heimberger, Amy, Levine, Jonathan, Verhaak, Roel
Izdano u Neuro Oncol (2019)

IT-22 TARGETING THE IMMUNE CHECKPOINT NETWORK WITH miR-138 EXERTS THERAPEUTIC EFFICACY IN MURINE MODELS OF GLIOMA

od Nduom, Edjah K., Wei, Jun, Kong, Ling-Yuan, Xu, Shuo, Gabrusiewicz, Konrad, Ling, Xiaoyang, Huang, Neal, Qiao, Wei, Zhou, Shouhao, Ivan, Cristina, Chen, Jie Qing, Ji, Yongjie, Radvanyi, Laszlo, Fuller, Greg N., Gilbert, Mark, Conrad, Charles A., Overwijk, Willem, Calin, George A., Heimberger, Amy B.
Izdano 2014

PD-L1 expression and prognostic impact in glioblastoma

od Nduom, Edjah K., Wei, Jun, Yaghi, Nasser K., Huang, Neal, Kong, Ling-Yuan, Gabrusiewicz, Konrad, Ling, Xiaoyang, Zhou, Shouhao, Ivan, Cristina, Chen, Jie Qing, Burks, Jared K., Fuller, Greg N., Calin, George A., Conrad, Charles A., Creasy, Caitlin, Ritthipichai, Krit, Radvanyi, Laszlo, Heimberger, Amy B.
Izdano u Neuro Oncol (2016)

Osteopontin mediates glioblastoma-associated macrophage infiltration and is a potential therapeutic target

od Wei, Jun, Marisetty, Anantha, Schrand, Brett, Gabrusiewicz, Konrad, Hashimoto, Yuuri, Ott, Martina, Grami, Zacharia, Kong, Ling-Yuan, Ling, Xiaoyang, Caruso, Hillary, Zhou, Shouhao, Wang, Y. Alan, Fuller, Gregory N., Huse, Jason, Gilboa, Eli, Kang, Nannan, Huang, Xingxu, Verhaak, Roel, Li, Shulin, Heimberger, Amy B.
Izdano u J Clin Invest (2018)

Immune modulatory nanoparticle therapeutics for intracerebral glioma

od Yaghi, Nasser K., Wei, Jun, Hashimoto, Yuuri, Kong, Ling-Yuan, Gabrusiewicz, Konrad, Nduom, Edjah K., Ling, Xiaoyang, Huang, Neal, Zhou, Shouhao, Kerrigan, Brittany C. Parker, Levine, Jonathan M., Fajt, Virginia R., Levine, Gwendolyn, Porter, Brian F., Marcusson, Eric G., Tachikawa, Kiyoshi, Chivukula, Padmanabh, Webb, David C., Payne, Joseph E., Heimberger, Amy B.
Izdano u Neuro Oncol (2017)

AML-induced osteogenic differentiation in mesenchymal stromal cells supports leukemia growth

od Battula, V. Lokesh, Le, Phuong M., Sun, Jeffrey C., Nguyen, Khoa, Yuan, Bin, Zhou, Ximin, Sonnylal, Sonali, McQueen, Teresa, Ruvolo, Vivian, Michel, Keith A., Ling, Xiaoyang, Jacamo, Rodrigo, Shpall, Elizabeth, Wang, Zhiqiang, Rao, Arvind, Al-Atrash, Gheath, Konopleva, Marina, Davis, R. Eric, Harrington, Melvyn A., Cahill, Catherine W., Bueso-Ramos, Carlos, Andreeff, Michael
Izdano u JCI Insight (2017)